Breast cell line dose response to target inhibition measured by high throughput microscopy - Dataset (ID:20136)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Units | Timepoint | Timepoint Units | Measured pERK (Alexa 488) | Measured p-Rb (Alexa 568) | Alexa Fluor 647 | Measured p-Akt/p-4EBP1/p-S6 (Alexa 647) | Image |
---|---|---|---|---|---|---|---|---|---|---|
Gefitinib | T47D | 100.0 | nM | 6 | hr | 165.65 | 99.07 | p-Akt | 102.82 | |
Gefitinib | T47D | 100.0 | nM | 24 | hr | 153.51 | 95.94 | p-Akt | 73.78 | |
Torkinib | T47D | 31.6 | nM | 6 | hr | 157.45 | 81.63 | p-Akt | 32.89 | |
Torkinib | T47D | 31.6 | nM | 24 | hr | 120.65 | 41.23 | p-Akt | 22.89 | |
GSK1059615 | T47D | 100.0 | nM | 6 | hr | 158.85 | 79.78 | p-Akt | 56.09 | |
GSK1059615 | T47D | 100.0 | nM | 24 | hr | 151.19 | 70.37 | p-Akt | 36.54 | |
MK2206 | T47D | 100.0 | nM | 6 | hr | 95.92 | 42.78 | p-Akt | 7.64 | |
MK2206 | T47D | 100.0 | nM | 24 | hr | 135.00 | 67.06 | p-Akt | 17.61 | |
Triciribine | T47D | 100.0 | nM | 6 | hr | 113.51 | 61.24 | p-Akt | 15.00 | |
Triciribine | T47D | 100.0 | nM | 24 | hr | 172.96 | 80.38 | p-Akt | 42.98 | |
Dactolisib | T47D | 100.0 | nM | 6 | hr | 101.93 | 53.36 | p-Akt | 8.50 | |
Dactolisib | T47D | 100.0 | nM | 24 | hr | 121.98 | 38.12 | p-Akt | 19.84 | |
Dactolisib | T47D | 3.16 | nM | 24 | hr | 138.41 | 87.20 | p-Akt | 40.75 | |
MK2206 | T47D | 3.16 | uM | 6 | hr | 117.01 | 52.23 | p-Akt | 7.58 | |
Gefitinib | T47D | 316.0 | nM | 24 | hr | 159.76 | 114.64 | p-Akt | 81.98 | |
Triciribine | T47D | 3.16 | uM | 24 | hr | 169.39 | 62.41 | p-Akt | 33.47 | |
Triciribine | T47D | 3.16 | uM | 6 | hr | 117.72 | 59.79 | p-Akt | 12.45 | |
Dactolisib | T47D | 3.16 | uM | 6 | hr | 86.04 | 36.41 | p-Akt | 6.31 | |
Dactolisib | T47D | 3.16 | uM | 24 | hr | 119.38 | 40.84 | p-Akt | 13.33 | |
Gefitinib | T47D | 0 (control) | 6 | hr | 176.65 | 97.90 | p-Akt | 103.18 | ||
Gefitinib | T47D | 100.0 | nM | 24 | hr | 143.88 | 111.89 | p-4EBP1 | 390.92 | |
Torkinib | T47D | 31.6 | nM | 24 | hr | 124.43 | 49.09 | p-4EBP1 | 182.93 | |
GSK1059615 | T47D | 100.0 | nM | 6 | hr | 161.08 | 79.36 | p-4EBP1 | 506.97 | |
Dactolisib | T47D | 31.6 | nM | 24 | hr | 124.69 | 58.78 | p-S6 | 12.06 | |
Dactolisib | T47D | 31.6 | nM | 6 | hr | 90.16 | 29.57 | p-S6 | 4.68 |